Burns
Volume 33, Issue 1 , Pages 81-86 , February 2007

Effects of gabapentin on morphine consumption and pain in severely burned patients

  • Olivier Cuignet

      Affiliations

    • Burn Center, Military Hospital, Rue Bruyn 1, 1120 Brussels, Belgium
    • ,
  • Jean Pirson

      Affiliations

    • Burn Center, Military Hospital, Rue Bruyn 1, 1120 Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 2 2644810.
    • ,
  • Olivier Soudon

      Affiliations

    • Department of Anesthesiology, Université Catholique de Louvain, Belgium
    • ,
  • Martin Zizi

      Affiliations

    • ACOS WB, Division of Biostatistics and Epidemiology, Belgian Ministry of Defense, Belgium

,Accepted 18 April 2006.

References 

  1. Latarjet J. The pain from burns. Pathol Biol. 2002;50(March (2)):127–133[Paris]
  2. Pedersen JL. Inflammatory pain in experimental burns in man. Dan Med Bull. 2000;47(June (3)):168–195
  3. Dirks J, Moiniche S, Helsted KL, Dahl JB. Mechanisms of postoperative pain: clinical indication for a contribution of central neuronal sensitisation. Anesthesiology. 2002;97:1591–1596
  4. Woolf CJ. A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs. 1994;47(Suppl. 5):1–9[discussion 46–47]
  5. Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57(May (5)):451–462
  6. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther. 2003;25(January (1)):81–104
  7. Dirks J, Petersen KL, Rowbotham MC, Dahl JB. Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization. Anesthesiology. 2002;97(July (1)):102–107
  8. Turan A, Karamanlioglu B, Memis D, et al. The analgesic effects of gabapentin after total abdominal hysterectomy. Anesth Analg. 2004;98(May (5)):1370–1373
  9. Werner MU, Perkins FM, Holte K, et al. Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med. 2001;26(July–August (4)):322–328
  10. Dierking G, Duedahl TH, Rasmussen ML, et al. Effects of gabapentin on postoperative morphine consumption and pain after abdominal hysterectomy: a randomized, double-blind trial. Acta Anaesthesiol Scand. 2004;48(March (3)):322–327
  11. Eckhardt K, Ammon S, Hofmann U. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg. 2000;91(July (1)):185–191
  12. Junger H, Moore AC, Sorkin LS. Effects of full-thickness burns on nociceptor sensitization in anesthetized rats. Burns. 2002;28(December (8)):772–777
  13. Nozaki-Taguchi N. Pharmacology of spinal glutamatergic receptors in post-thermal injury-evoked tactile allodynia and thermal hyperalgesia. Anesthesiology. 2002;96(3):617–626
  14. Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-d-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth. 1996;76:829–834
  15. Ilkjaer S, Dirks J, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-d-aspartate receptor antagonist (dextrometorphan) on primary and secondary hyperalgesia in humans. Br J Anaesth. 1997;79:600–605
  16. Mao J, Chen LL. Gabapentin in pain management. Anesth Analg. 2000;91(September (3)):680–687
  17. Gilron I. Is gabapentin a “broad-spectrum” analgesic?. Anesthesiology. 2002;97(September (3)):537–539
  18. Jun JH, Yaksh TL. The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg. 1998;86(February (2)):348–354
  19. Jones DL, Sorkin LS. Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia. Brain Res. 1998;810(November (1–2)):93–99
  20. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg. 2002;95(October (4)):985–991
  21. Cuignet O, Pirson J, Boughrouph J, Duville D. The efficacy of continuous fascia iliaca compartment block for pain management in burn patients undergoing skin grafting procedures. Anesth Analg. 2004;98(April (4)):1077–1081
  22. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther. 2004;11(September–October (5)):354–365
  23. Risdahl JM, Khanna KV, Peterson PK, Molitor TW. Opiates and infection. J Neuroimmunol. 1998;83(March (1–2)):4–18[Review]
  24. Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab. 2000;85(June (6)):2215–2222
  25. Freye E, Latasch L. Development of opioid tolerance—molecular mechanisms and clinical consequences. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003;38(January (1)):14–26
  26. Matthews E. A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology. 2002;96(3):633–640
  27. Burkhard G. Gabapentin: the first preemptive anti-hyperalgesic for opioid withdrawal hyperalgesia. Anesthesiology. 2003;98(June (6)):1520–1521[author reply 1521–1522]
  28. Ossipov MH, Lai J, King T, Vanderah TW, et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol. 2004;61(October (1)):126–148
  29. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280(December (21)):1837–1842
  30. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280(December (21)):1831–1836

PII: S0305-4179(06)00152-5

doi: 10.1016/j.burns.2006.04.020

Burns
Volume 33, Issue 1 , Pages 81-86 , February 2007

Article Tools

* Image Usage & Resolution